According to the publisher, Asia Pacific cell and gene therapy market size is expected to record a CAGR of 20.7% during 2023-2027 to reach US$12.477 billion by 2027, increasing from US$4.871 billion in 2023. Over the last five years, the sector has recorded a CAGR of 24.6% to reach US$3.908 billion in 2022.
This offering is a bundled offering, combining 5 countries and a key report covering Asia Pacific region. This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry in Asia Pacific region. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product.
This offering is a bundled offering, combining 5 countries and a key report covering Asia Pacific region. This report provides an in-depth data-centric analysis of the emerging opportunities in cell and gene therapy industry in Asia Pacific region. It covers a detailed view of market size and forecast across various segments such as by different therapy segment, type of therapy, the purpose of manufacturing, type of cell, route of administration, delivery mode, source of cell, source of manufacturing, therapeutic class, technology, end-user and by product.
This title is a bundled offering, combining the following 6 reports, covering 215+ tables and 294+ figures:
- Country Report 1 - Asia Pacific Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 2 - China Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 3 -Japan Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 4 -Australia Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 5 - India Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
- Country Report 6 - South Korea Cell & Gene Therapy Business and Investment Opportunities Databook - Q2 2023 Update
Scope
This report provides an in-depth, data-centric analysis of the Asia Pacific cell and gene therapy market 2018-2027. Below is a summary of key market segments:Cell & Gene Therapy Market Size by Different Therapy Segment, 2018-2027
- Cell and Gene Modified Cell Therapies
- Gene Therapy and Genome Therapy
- DNA & RNA Therapeutics
Cell & Gene Therapy Market Size by Purpose of Manufacturing
- Commercial
- Clinical
Cell & Gene Therapy Market Size by Product
- Abecma
- Amondys
- Breyanzi
- Carvykti
- Givlaari
- Kimmtrak
- Kymriah
- Leqvio
- Luxturna
- Onpattro
- Oxlumo
- Rethymic
- Skysona
- Stratagraft
- Tecartus
- Tegsedi
- Viltepso
- Vyondys
- Yescarta
- Zolgensma
- Zynteglo
Cell & Gene Therapy Market Size by Route of Administration
- Injectables
- Infusions
- Bioscaffolds
- Topicals
Cell & Gene Therapy Market Size by Type of Cell
- CAR-T Cell
- TCR Cell
Cell & Gene Therapy Market Size by Type of Therapy
- T-Cell Therapies
- NK Cell
- Dendritic Cell Therapies
- Stem Cell Therapies
Cell & Gene Therapy Market Size by Source of Cell
- Autologous
- Allogenic
Cell & Gene Therapy Market Size by Delivery Mode
- In vivo
- ex-vivo
Cell & Gene Therapy Market Size by Source of Manufacturing
- In-House
- Contract Manufacturing
Cell & Gene Therapy Market Size by Therapeutic Class
- Oncology
- Neurology
- Ophthalmology
- Musculoskeletal
- Others
Cell & Gene Therapy Market Size by Technology
- Viral Vector Technology
- Cell Immortalization Technology
- Genome Editing Technology
- Others
Cell & Gene Therapy Market Size by End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospital & Clinics
Reasons to buy
- In-depth understanding of cell and gene therapy market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Asia Pacific.
- Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
- Get market share analysis by end users: Get a detailed analysis across different end users such as pharmaceutical, biotechnology companies, academic & research institutes, and by hospitals & clinics within the Asia Pacific.
Table of Contents
This title is a bundled offering, combining the following 6 reports, covering 215+ tables and 294+ figures:
1. About this Report
3 Cell and Gene Therapy Market Share by Different Therapy Segment, 2018-2027
4 Cell and Gene Therapy Market Share by Purpose of Manufacturing, 2018-2027
6 Cell and Gene Therapy Market Share by Route of Administration, 2018-2027
7 Cell and Gene Therapy Market Share by Type of Diseases, 2018-2027
8 Cell and Gene Therapy Market Share by Type of Cell, 2018-2027
9 Cell and Gene Therapy Market Share by Therapy, 2018-2027
10 Cell and Gene Therapy Market Share by Source of Cell, 2018-2027
11 Cell and Gene Therapy Market Share by Delivery Mode, 2018-2027
12 Cell and Gene Therapy Market Share by Source of Manufacturing, 2018-2027
13 Cell and Gene Therapy Market Share by Therapeutic Class, 2018-2027
14 Cell and Gene Therapy Market Share by Technology, 2018-2027
15 Cell and Gene Therapy Market Share by End User, 2018-2027
16 Further Reading
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 300 |
| Published | August 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 4.87 Billion |
| Forecasted Market Value ( USD | $ 12.48 Billion |
| Compound Annual Growth Rate | 20.6% |
| Regions Covered | Asia Pacific |
